Cover ImageSALE
Market Research Report

Global CRO Market 2015-2019

Published by TechNavio (Infiniti Research Ltd.) Product code 322248
Published Content info 75 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global CRO Market 2015-2019
Published: December 31, 2014 Content info: 75 Pages
Description

About CRO

Organizations that support outsourced research services for the Pharmaceutical, Biotechnology, and Medical Devices industries are called CROs. The nature of engagement of outsourced services is generally on contractual basis. This helps the vendors to control their R&D expenditure and concentrate on their core skills. CROs help vendors expand their capacities from clinical trials to healthcare regulatory submissions, biostatistics, and data management work. Furthermore, CROs have also started offering services at all phases (pre-clinical, phase I, phases II & IIIa, phases IIIb & IV, labs, and others) of drug development and discovery. CROs have built their capabilities from the earliest to the latest stages of drug development with emphasis on partnership, collaboration, and fee for service models.

TechNavio's analysts forecast the Global CRO market to grow at a CAGR of 9.83 percent over the period 2014-2019.

Covered in this Report

The CRO market can be divided into two segments: Early-stage Development Services and Late-stage Development Services. To calculate the market size, the report considers the revenue generated from the sales of outsourcing of R&D services to CROs by global pharmaceutical and biopharmaceutical vendors.

TechNavio's report, Global CRO Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global CRO market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Covance
  • Parexel International
  • PRA Health Sciences
  • Quintiles Translational

Market Driver

  • Increased Outsourcing of R&D Activities
  • For a full, detailed list, view our report

Market Challenge

  • Shortage of CRO Staff
  • For a full, detailed list, view our report

Market Trend

  • Increase in Number of M&A
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents
Product Code: IRTNTR4915

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Type of Service

  • 07.1. Global Early Stage Development Services Market
    • 07.1.1. Market Size and Forecast
  • 07.2. Global Late Stage Development Services Market
    • 07.2.1. Market Size and Forecast

08. Market Segmentation by Therapeutic Area

09. Geographical Segmentation

  • 09.1. CRO Market in Americas
    • 09.1.1. CRO Market in the US
  • 09.2. CRO Market in EMEA Region
  • 09.3. CRO Market in APAC Region
    • 09.3.1. CRO Market in China
    • 09.3.2. CRO Market in India

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

  • 17.1. Competitive Scenario
    • 17.1.1. Key News
    • 17.1.2. Mergers and Acquisitions
  • 17.2. Market Share Analysis 2014
  • 17.3. Other Prominent Vendors

18. Key Vendor Analysis

  • 18.1. Covance Inc.
    • 18.1.1. Key Facts
    • 18.1.2. Business Overview
    • 18.1.3. Business Segmentation by Revenue 2013
    • 18.1.4. Product Portfolio by Revenue 2013
    • 18.1.5. Business Segmentation by Revenue 2012 and 2013
    • 18.1.6. Geographical Segmentation by Revenue 2013
    • 18.1.7. Business Strategy
    • 18.1.8. Recent Developments
    • 18.1.9. SWOT Analysis
  • 18.2. Quintiles Translational Corp.
    • 18.2.1. Key Facts
    • 18.2.2. Business Overview
    • 18.2.3. Business Segmentation by Revenue 2013
    • 18.2.4. Product Portfolio by Revenue 2013
    • 18.2.5. Business Segmentation by Revenue 2012 and 2013
    • 18.2.6. Geographical Segmentation by Revenue 2013
    • 18.2.7. Business Strategy
    • 18.2.8. Recent Developments
    • 18.2.9. SWOT Analysis
  • 18.3. Parexel International Corp.
    • 18.3.1. Key Facts
    • 18.3.2. Business Overview
    • 18.3.3. Business Segmentation by Revenue 2013
    • 18.3.4. Product Portfolio by Revenue 2013
    • 18.3.5. Business Segmentation by Revenue 2012 and 2013
    • 18.3.6. Geographical Segmentation by Revenue 2013
    • 18.3.7. Business Strategy
    • 18.3.8. Recent Developments
    • 18.3.9. SWOT Analysis
  • 18.4. PRA Health Sciences Inc.
    • 18.4.1. Key Facts
    • 18.4.2. Business Overview
    • 18.4.3. Business Segmentation by Revenue 2013
    • 18.4.4. Product Portfolio by Revenue 2013
    • 18.4.5. Business Segmentation by Revenue 2012 and 2013
    • 18.4.6. Geographical Segmentation by Revenue 2013
    • 18.4.7. Business Strategy
    • 18.4.8. Recent Developments
    • 18.4.9. SWOT Analysis

19. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: The Players in Clinical Research
  • Exhibit 3: Global CRO Market 2014-2019 (US$ billion)
  • Exhibit 4: Global CRO Market Segmentation by Type of Service
  • Exhibit 5: Global CRO Market Segmentation by Type of Service 2014
  • Exhibit 6: Global CRO Market Segmentation by Type of Activity 2014
  • Exhibit 7: Global Early Stage Development Services Market 2014-2019 (US$ billion)
  • Exhibit 8: Global Late Stage Development Services Market 2014-2019 (US$ billion)
  • Exhibit 9: Global CRO Market Segmentation by Type of Service 2014-2019 (US$ billion)
  • Exhibit 10: Global CRO Market Segmentation by Type of Service 2014-2019 (in Percent)
  • Exhibit 11: R&D Clinical Trial Pipeline by Therapeutic Area 2014
  • Exhibit 12: Global CRO Market by Geographical Segmentation 2014
  • Exhibit 13: Global CRO Market by Geographical Segmentation 2014-2019 (US$ billion)
  • Exhibit 14: Global CRO Market by Geographical Segmentation 2014-2019 (in Percent)
  • Exhibit 15: CRO Market in Americas 2014-2019 (US$ billion)
  • Exhibit 16: CRO Market in the US 2014-2019 (US$ billion)
  • Exhibit 17: CRO Market in EMEA Region 2014-2019 (US$ billion)
  • Exhibit 18: CRO Market in APAC Region 2014-2019 (US$ billion)
  • Exhibit 19: CRO Market in China 2014-2019 (US$ billion)
  • Exhibit 20: CRO Market in India 2014-2019 (US$ billion)
  • Exhibit 21: Research Cost Comparison in US and India
  • Exhibit 22: Number of Drugs Going Off-patent in 2013-2016
  • Exhibit 23: Key Factors in Failure of Clinical Trials
  • Exhibit 24: Strategic Alliances Between Large Biopharma Companies And CRO's
  • Exhibit 25: Key Deals in the CRO and related services space
  • Exhibit 26: Global CRO Market by Vendor Segmentation 2014
  • Exhibit 27: Quintiles Market Sales by Segment 2013
  • Exhibit 28: Parexel International Segments
  • Exhibit 29: Percentage Market Share of Top 6 CRO's
  • Exhibit 24: Covance Inc.: Business Segmentation by Revenue 2013
  • Exhibit 25: Covance Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 26: Covance Inc.: Sales by Geography 2013
  • Exhibit 24: Quintiles Translational Corp.: Business Segmentation by Revenue 2013
  • Exhibit 25: Quintiles Translational Corp.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 26: Quintiles Translational Corp.: Sales by Geography 2013
  • Exhibit 24: Parexel International Corp.: Business Segmentation by Revenue 2013
  • Exhibit 25: Parexel International Corp.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 26: Parexel International Corp.: Sales by Geography 2013
  • Exhibit 24: PRA Health Sciences Inc.: Business Segmentation by Revenue 2013
  • Exhibit 25: PRA Health Sciences Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 26: PRA Health Sciences Inc.: Sales by Geography 2013
Back to Top